{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T21:25:51Z","timestamp":1764192351264},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.transproceed.2010.08.043","type":"journal-article","created":{"date-parts":[[2010,11,20]],"date-time":"2010-11-20T09:24:13Z","timestamp":1290245053000},"page":"3513-3516","source":"Crossref","is-referenced-by-count":8,"title":["Low-Dose Calcineurin Inhibitor Regimen Combined With Mammalian Target of Rapamycin Inhibitors Preserves Kidney Functions in Renal Transplant Recipients Without Allograft Nephropathy"],"prefix":"10.1016","volume":"42","author":[{"given":"S.","family":"Kacar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gurkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Var\u0131lsuha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tilif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2010.08.043_bib1","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.transproceed.2007.06.066","article-title":"mTOR inhibitors: do they help preserve renal function?","volume":"39","author":"Moro","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.08.043_bib2","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1161\/01.CIR.0000150332.42276.69","article-title":"Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs","volume":"110","author":"Lidenfeld","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2010.08.043_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.TP.0000128636.70499.6E","article-title":"Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.08.043_bib4","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2010.08.043_bib5","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1523-1755.2005.00558.x","article-title":"Post-transplantation chronic renal damage in nonrenal transplant recipients","volume":"68","author":"Stratta","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2010.08.043_bib6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.transproceed.2006.12.026","article-title":"Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: effect on renal function and proteinuria","volume":"39","author":"Morales","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.08.043_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.trre.2007.12.001","article-title":"mToR inhibitors-induced proteinuria: mechanisms, significance, and management","volume":"22","author":"Letavernier","year":"2008","journal-title":"Transplant Rev"},{"key":"10.1016\/j.transproceed.2010.08.043_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post-transplant renal function in the first year predicts long-term kidney transplant survival","volume":"62","author":"Hariharan","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2010.08.043_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1523-1755.1998.00744.x","article-title":"Association of chronic kidney graft failure with recipient blood pressure","volume":"53","author":"Opelz","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2010.08.043_bib10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1600-6143.2005.01177.x","article-title":"Complete avoidance of calcineurin inhibitors in-renal transplantation: a randomized trial comparing sirolimus and tacrolimus","volume":"6","author":"Larson","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.08.043_bib11","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/01.tp.0000185200.17589.74","article-title":"Proteinuria following a switch from calcineurin inhibitors to sirolimus","volume":"80","author":"Letavernier","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.08.043_bib12","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/ndt\/gfh957","article-title":"Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus","volume":"20","author":"Bumbea","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2010.08.043_bib13","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/01.tp.0000184623.35773.6a","article-title":"Conversion from cyclosporine to sirolimus in stable renal transplant recipients","volume":"80","author":"Sennesael","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.08.043_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa022602","article-title":"The renal arterial resistance index and renal allograft survival","volume":"349","author":"Radermacher","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2010.08.043_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.transproceed.2005.12.023","article-title":"Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients","volume":"38","author":"Boratynska","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.08.043_bib16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1600-6143.2005.01195.x","article-title":"Sirolimus associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism","volume":"6","author":"Straathof-Galena","year":"2006","journal-title":"Am J Transplant"},{"issue":"3 suppl","key":"10.1016\/j.transproceed.2010.08.043_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0041-1345(03)00244-6","article-title":"Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience","volume":"35","author":"Morelon","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.08.043_bib18","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine","volume":"67","author":"Groth","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.08.043_bib19","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/00007890-200004150-00009","article-title":"Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients","volume":"69","author":"Kreis","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.08.043_bib20","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1111\/j.1600-6143.2005.01019.x","article-title":"Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus","volume":"5","author":"Meier-Kriesche","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.08.043_bib21","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00007890-199810270-00013","article-title":"Immunosuppressive effects and safety of a sirolimus\/cyclosporine combination regimen for renal transplantation","volume":"66","author":"Kahan","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.08.043_bib22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-6143.2005.01193.x","article-title":"Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study","volume":"6","author":"Vitko","year":"2006","journal-title":"Am J Transplant"},{"issue":"suppl 2","key":"10.1016\/j.transproceed.2010.08.043_bib23","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.2215\/CJN.03510807","article-title":"Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result","volume":"3","author":"Srinivas","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2010.08.043_bib24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(99)03882-9","article-title":"Sirolimus-tacrolimus combination immunosuppression","volume":"355","author":"McAlister","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2010.08.043_bib25","doi-asserted-by":"crossref","unstructured":"Hartwig T, Pridoehl O, Witzigmann H, et al: Low-dose sirolimus and tacrolimus in kidney transplantation: first results of a single center experience. Transplant Proc 33:3226, 200","DOI":"10.1016\/S0041-1345(01)02372-7"},{"key":"10.1016\/j.transproceed.2010.08.043_bib26","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/j.1600-6143.2004.00590.x","article-title":"Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction","volume":"4","author":"Diekmann","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.08.043_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.transproceed.2007.11.005","article-title":"The effect of sirolimus in the development of chronic allograft nephropathy","volume":"40","author":"G\u00fcrkan","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.08.043_bib28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1399-0012.2007.00645.x","article-title":"Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus-based therapy: a multivariate analysis of results at five years","volume":"21","author":"Legendre","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2010.08.043_bib29","first-page":"194","article-title":"Sirolimus (Rapamune, rapamycin) is more effective than azathioprine to reduce the incidence of acute renal allograft rejection episodes when used in combination with cyclosporine and prednisone: a phase III US multicentral trial","volume":"356","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2010.08.043_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A world wide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts","volume":"27;71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.08.043_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ndt\/gfh639","article-title":"Nephrotoxicity of rapamycin: an emerging problem in clinical practice","volume":"20","author":"Marti","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2010.08.043_bib32","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","article-title":"Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence","volume":"7","author":"Hiremath","year":"2007","journal-title":"Am J Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510012704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510012704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T11:54:18Z","timestamp":1559822058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134510012704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0041134510012704"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2010.08.043","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}